| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0006 |